$CYDY

We have a $2.75 Price Target on CytoDyn ( CYDY ) in the Next 6 to 12 Months. The stock's current price is around $0.32. CytoDyn Inc. is a clinical-stage biotechnology company focused on developing leronlimab, a monoclonal antibody targeting the CCR5 receptor, with applications in HIV, ...